Next stop: Kilimanjaro 2026 for Damon Runyon Cancer Research Foundation Meet the team of biotech leaders raising $1 million for cancer research and hiking up the highest peak in Africa. timmermanreport.com/2025/09/next...

Why is Vineeta Agarwala joining the Timmerman Traverse for a 3rd time on Oct. 4? Watch.

Timmerman Traverse for Life Science Cares raises another $1.1M to fight poverty. timmermanreport.com/2025/08/timm...

CAR-T cells against solid tumors. Listen to Sabah Oney, CEO of Dispatch Biotherapeutics, on The Long Run. timmermanreport.com/2025/08/car-...

VIDEO: Conversation with Phil Sharp and Bill Haney about 'Cracking the Code.' Documentary film about an inspiring life in science. timmermanreport.com/2025/08/vide...

Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...

Sublime scenery. Smiling faces. Thanks to the sponsors of the Timmerman Traverse for Damon Runyon Cancer Research Foundation. Watch this for 90 seconds of joy. www.youtube.com/watch?v=LwzE...

Finding Therapies in Long Non-Coding RNA. John Rinn of University of Colorado and Lincswitch Therapeutics is the latest guest on The Long Run. Available on Apple Podcasts, Spotify, and YouTube. timmermanreport.com/2025/06/find...

Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...

Request an Invitation to the Timmerman Traverse. timmermanreport.com/2025/06/requ...

A New (and Old) Idea for Cardiovascular Disease & Diabetes. @ethanjweiss.bsky.social and Josh Lehrer of Marea Therapeutics are the latest guests on The Long Run. timmermanreport.com/2025/05/a-ne...

Reclaiming Biotech's Edge: In Defense of Taking Disciplined Risk. Guest editorial by Anika Gupta Vatsa. timmermanreport.com/2025/05/recl...

Timmerman Traverse for @lifesciencecares.bsky.social is at $535,178 in pending and closed donations. Halfway to the $1M team goal with three months to go. Thanks to major sponsors Fenwick & West, KCap Biotechnology Fund and HSBC Innovation Banking. Looking forward to our PNW adventure!

Biologic Drug Discovery Made Faster. Peyton Greenside of BigHat Biosciences is the latest guest on The Long Run podcast. timmermanreport.com/2025/05/biol...

A Sublime Experience. See the photo highlights of Timmerman Traverse for Damon Runyon Cancer Research Foundation. timmermanreport.com/2025/05/a-su...

Honored.

We all made it! The Timmerman Traverse for Damon Runyon Cancer Research Foundation team arrived at Everest Base Camp (elev. 17,600 feet) on Apr. 23, 2025. Another awe-inspiring day in the mountains, supporting brave and bold cancer research. Thanks to all who supported this marvelous experience.

Views from Day 7 of Timmerman Traverse for Damon Runyon Cancer Research Foundation.

Stunning views from Timmerman Traverse for Damon Runyon Cancer Research Foundation. Day 5. We’re at Dingboche, elevation 14,300 ft. The Himalayas in full glory.

What US Biotech Can Do to Meet the Moment. By David Li, CEO of SF-based Meliora Therapeutics. timmermanreport.com/2025/04/a-ne...

Great article by @nobelprize.bsky.social laureate @ardemp.bskyverified.social outlining the health, economic and national security benefits of US biomedical research, and the devastation of government efforts to destroy our leading edge. www.cnn.com/2025/04/09/h...

Dr. Larry Corey was a fan of the Superman comics as a kid. Now he's looking for a hero in a red cape to stand up for mRNA vaccines and therapies. timmermanreport.com/2025/04/we-n...

A favorite sign from the Saturday rally in Seattle.

Meet the 2025 Timmerman Traverse for Life Science Cares 2025 team. Men and women on a mission to raise $1 million to fight poverty in BOS, SF, SD, PHI and NYC. Top sponsor: Fenwick & West. CC @robperez.bsky.social timmermanreport.com/2025/04/meet...

Goal: the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit the fundraising goal of $700,000 for high-risk / high-reward cancer research. Team gearing up for trek to Everest Base Camp. timmermanreport.com/2025/04/timm...

Longevity is Having a Moment, and the Secret Weapon of GLP1 Weight Loss Medicines. Two smart new pieces by @dshaywitz.bsky.social timmermanreport.com/2025/03/long... timmermanreport.com/2025/03/glp-...

A Moment of Peril and Promise. (Sub. Req.) timmermanreport.com/2025/03/sole...

I'll be in Boston tomorrow to interview George Church, Abbie Celniker, and Bruce Booth at the MassBio State of Possible conference. @massbio.bsky.social. www.massbio.org/state-of-pos...

NIH Cuts Threaten to Cede US Life Science Dominance to China. Guest editorial by state biotech leaders from Ohio, North Carolina, Washington and Michigan. timmermanreport.com/2025/03/nih-...

How a Dark Horse Candidate Is Upending the Sequencing Market. By Joe Horsman, biotech investor at Madrona. timmermanreport.com/2025/03/how-...

See the photos from the TR10 West party. timmermanreport.com/2025/03/see-...

See the photos from the TR10 East party. timmermanreport.com/2025/03/see-...

Why cell & gene therapy companies should talk with RFK Jr. Guest editorial by Tim Hunt, CEO of Alliance for Regenerative Medicine. timmermanreport.com/2025/03/why-...

Arbor Survives Winter, Gets $73.9M to Take Gene Editing Therapy to the Clinic. timmermanreport.com/2025/03/arbo...

The new frontier of CAR-T cell therapies made in the body. Listen to Andy Scharenberg, CEO of Umoja Biopharma, on The Long Run. timmermanreport.com/2025/03/car-...

Wonderful to see Brad Loncar and so many friends and supporters at the TR10 West Coast party last night. It's rough out there. But there's still plenty to be thankful for and celebrate in the biotech community. www.biotechtv.com/post/timmerm...

NIH cuts are hitting young scientists the hardest. By David Baker. timmermanreport.com/2025/03/davi...

Standing up for Science. A report from the rally in Seattle by Arjun Kumar. timmermanreport.com/2025/03/scie...

Technology to Accelerate Drug Discovery. Najat Khan of @recursionpharma.bsky.social is the latest guest on The Long Run. timmermanreport.com/2025/03/a-wo...

How to Know When a Company Should Throw in the Towel. By Alex Harding. timmermanreport.com/2025/02/how-...

Good interview. www.sciencefriday.com/segments/aaa...

Defend Young Scientists. timmermanreport.com/2025/02/stan...

Defend the FDA. timmermanreport.com/2025/02/defe...

Zero-Toll Medicine. Thought-provoking guest editorial by D.A. Wallach. timmermanreport.com/2025/02/zero...

Defend the NIH. timmermanreport.com/2025/02/defe...

Building a fully-integrated biopharma company for muscle disorders. Robert Blum of Cytokinetics is the latest guest on The Long Run. Sponsored by Chordoma Foundation. timmermanreport.com/2025/02/buil...

Speaking up for science, even when inconvenient. By Steve Holtzman, retired biotech CEO, Nov. 21. timmermanreport.com/2024/11/spea...

Rethinking Risk-Benefit in Sickle Cell Disease Therapy. By Dr. Alan Anderson. timmermanreport.com/2025/02/alig...

Tickets are SOLD OUT for the TR10 East Coast anniversary party Mar. 6 in Cambridge, Mass. Tickets still available for TR10 West Coast party Mar. 13. Register here. www.eventbrite.com/e/tr10-west-...

Timmerman Report Turns 10. timmermanreport.com/2025/02/timm...